Prelude Therapeutics Announces $25 Million Private Placement

WILMINGTON, Del., Dec. 11, 2023 -- Prelude Therapeutics Incorporated  , a clinical-stage precision oncology company, today announced a private placement that the Company estimates will result in...

Related Keywords

United States , Helen Shik , Kris Vaddi , Lindsey Trickett , Exchange Commission , Nasdaq , Prelude Therapeutics Incorporated , Linkedin , Shik Communications , Therapeutics Incorporated , Securities Act , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Markets ,